Prostate-Specific Membrane Antigen (PSMA) is a transmembrane glycoprotein overexpressed in prostate cancer (PCa) cells, making it an essential biomarker in oncologic imaging and targeted therapy (1). The gene discussed is FOLH1; the disease is prostate cancer.